HOME > TOP STORIES

TOP STORIES

ORGANIZATION RAD-AR Council to Set Guidelines for Information Provisioning on Ethical Drugs

February 12, 2013
ORGANIZATION JMA Exec. Mikami Wants a Hold on Info Disclosures Based on Transparency Guidelines

February 8, 2013
BUSINESS Pfizer Confident about Joining Top 3 in Japan Generic Sales by around 2015: Unit Chief Matsumori

February 7, 2013
REGULATORY NIHS to Accelerate Medical Innovation Research

February 7, 2013
BUSINESS Novartis Jettisons Key Evidence from Diovan Promotion

February 6, 2013
BUSINESS Nesp, Mircera Jostling for Market Shares of Pre-Dialysis CKD Patients

February 5, 2013
BUSINESS Aricept Fails to Meet Minimum Sales Target in Japan: Eisai

February 4, 2013
BUSINESS Marketing Ability Could Become Decisive Factor as All DPP-4 Inhibitors Are Likely to Obtain the Same Concurrent-use Indications

February 4, 2013
BUSINESS Daiichi Sankyo Sees 7.1% Sales Rise in April-December, Cuts Domestic Forecast for Nexium

February 1, 2013
REGULATORY CRO Association to Compile Guidelines for Third-Party Outsourcing after GCP Revision

February 1, 2013
ORGANIZATION Wholesale Industry FTC Prohibits Drink Donations at Academic Confabs, Keeps Pace with Drug Makers

January 31, 2013
REGULATORY 13 Generic Makers Slapped with Improvement Order due to South Korean Supplier’s GMP Violation

January 30, 2013
ORGANIZATION Wholesale Industry FTC Curbs Returns of Drugs to Be Discarded

January 29, 2013
BUSINESS Medipal Group Introduces Special Mini Cooler for New Orphan Drug

January 29, 2013
REGULATORY PAFSC First Committee on New Drugs to Discuss Approval of Japan’s First FD Treatment

January 28, 2013
BUSINESS Novartis, Sanofi Dissolve Partnership on Equa Copromotion

January 25, 2013
BUSINESS Transparency GL: Drug Makers Might Disclose Individual Payments Only Upon Request

January 24, 2013
BUSINESS Merck Serono Aims for Top 10 Slot in Oncology Field

January 23, 2013
BUSINESS Sanofi’s Dellegra Promotion to Home in on Stuffy Nose

January 22, 2013
BUSINESS Pfizer Detailing Infectious Disease Portfolios across Divisions

January 21, 2013

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?

Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…